PLASMA-LEVELS OF THE CALCIUM-BINDING L1-LEUKOCYTE PROTEIN - STANDARDIZATION OF BLOOD COLLECTION AND EVALUATION OF REFERENCE INTERVALS IN HEALTHY CONTROLS

被引:27
作者
DALE, I
机构
[1] ULLEVAL HOSP, BLOOD BANK, OSLO 1, NORWAY
[2] ULLEVAL HOSP, DEPT IMMUNOHAEMATOL, OSLO 1, NORWAY
关键词
BLOOD COLLECTION; L1; PROTEIN; NORMAL VALUES; PLASMA CONCENTRATION;
D O I
10.3109/00365519009104950
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Release of the calcium-binding protein L1 from blood granulocytes in vitro was found to be strongly influenced by anticoagulants and was accelerated during blood clotting. EDTA effectively inhibited this release. The material of choice for obtaining base-line L1 levels in blood is, therefore, EDTA plasma. Care should be taken to avoid admixture with cells from the buffy coat. The reference interval for L1 concentrations in plasma was established by testing samples from 533 blood donors. The L1 distribution proved in both sexes to be log-normal. The reference interval in females was 90 to 530 mu-g/l, and in males 120 to 660 mu-g/l. A positive correlation was found between the L1 level and the white blood cell count (r = 0.46, p = 0.0001).
引用
收藏
页码:837 / 841
页数:5
相关论文
共 17 条
[1]   THE LEUKOCYTE L1-PROTEIN - IDENTITY WITH THE CYSTIC-FIBROSIS ANTIGEN AND THE CALCIUM-BINDING MRP-8 AND MRP-14 MACROPHAGE COMPONENTS [J].
ANDERSSON, KB ;
SLETTEN, K ;
BERNTZEN, HB ;
DALE, I ;
BRANDTZAEG, P ;
JELLUM, E ;
FAGERHOL, MK .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1988, 28 (02) :241-245
[2]  
BABIOR BM, 1981, METHODS HEMATOLOGY, V3, P1
[3]  
BENNETT RM, 1976, J LAB CLIN MED, V88, P156
[4]  
Berntzen H B, 1988, Scand J Rheumatol Suppl, V76, P251
[5]   DISTRIBUTION OF A FORMALIN-RESISTANT MYELOMONOCYTIC ANTIGEN (L1) IN HUMAN-TISSUES .2. NORMAL AND ABERRANT OCCURRENCE IN VARIOUS EPITHELIA [J].
BRANDTZAEG, P ;
DALE, I ;
FAGERHOL, MK .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1987, 87 (06) :700-707
[6]   DISTRIBUTION OF A FORMALIN-RESISTANT MYELOMONOCYTIC ANTIGEN (L1) IN HUMAN-TISSUES .1. COMPARISON WITH OTHER LEUKOCYTE MARKERS BY PAIRED IMMUNOFLUORESCENCE AND IMMUNOENZYME STAINING [J].
BRANDTZAEG, P ;
DALE, I ;
FAGERHOL, MK .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1987, 87 (06) :681-699
[7]   QUANTITATION OF A HIGHLY IMMUNOGENIC LEUKOCYTE ANTIGEN (L1) BY RADIOIMMUNOASSAY - METHODOLOGICAL EVALUATION [J].
DALE, I ;
FAGERHOL, MK ;
FRIGARD, M .
JOURNAL OF IMMUNOLOGICAL METHODS, 1983, 65 (1-2) :245-255
[8]   DISTRIBUTION OF A NEW MYELOMONOCYTIC ANTIGEN (L1) IN HUMAN PERIPHERAL-BLOOD LEUKOCYTES - IMMUNOFLUORESCENCE AND IMMUNOPEROXIDASE STAINING FEATURES IN COMPARISON WITH LYSOZYME AND LACTOFERRIN [J].
DALE, I ;
BRANDTZAEG, P ;
FAGERHOL, MK ;
SCOTT, H .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1985, 84 (01) :24-34
[9]   PURIFICATION AND PARTIAL CHARACTERIZATION OF A HIGHLY IMMUNOGENIC HUMAN-LEUKOCYTE PROTEIN, THE L1-ANTIGEN [J].
DALE, I ;
FAGERHOL, MK ;
NAESGAARD, I .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1983, 134 (01) :1-6
[10]   EXPRESSION OF THE EPITHELIAL L1 ANTIGEN AS AN IMMUNOHISTOCHEMICAL MARKER OF SQUAMOUS-CELL CARCINOMA OF THE LUNG [J].
DALE, I ;
BRANDTZAEG, P .
HISTOPATHOLOGY, 1989, 14 (05) :493-502